Back

Effect of anti-fibrotic therapy on regression of myocardial fibrosis after TAVI: 'As-treated' analysis of the Reduce-MFA DZHK 25-trial

29 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in valvular heart disease: atrial fibrillation and mitral regurgitation Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Kristin Steinhaus

University Medical Centre of Gottingen (UMG), Goettingen (Germany)

6 More presentations in this session

Presentation thumbnail
SGLT-2 inhibitors in moderate-to-severe functional mitral regurgitation: a meta-analysis of randomized controlled trials
Doctor F. Stabile (Palermo, IT)
Abstract Slides Video
Presentation thumbnail
Transcatheter closure of secundum atrial septal defect in adult and paediatric population without transoesophageal echocardiography/general anaesthesia
Doctor S. Naganur (Chandigarh, IN)
Abstract Slides Video
Presentation thumbnail
Preoperative invasive coronary angiography before non-coronary cardiac surgery: diagnostic yield and impact on management in an african population.
Doctor J. Herbst (Cape Town, ZA)
Abstract Slides Video
Presentation thumbnail
Sex-specific inflammatory proteomic signatures predict aortic valve stenosis: evidence from multi-omics analyses
Doctor S. Shu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Exercise gas exchange, hemodynamics and clinical outcomes in patients with normal flow low gradient aortic stenosis
Doctor T. Sugimoto (Nagoya, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in valvular heart disease: atrial fibrillation and mitral regurgitation

The Event

Event poster

ESC Congress 2026

29 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
EVOLVED - Myocardial Fibrosis Burden and Early Intervention in Patients with Asymptomatic Severe Aortic Stenosis
30 August 2025
thumbnail
Congress Presentation
Incremental benefit of sodium–glucose cotransporter 2 inhibitor and mineralocorticoid receptor antagonist therapy in HFpEF with moderate mitral regurgitation: 24-month ambulatory cohort study
29 August 2026
thumbnail
Congress Presentation
LUMINARA: a prospective RCT of a once daily oral relaxin agonist for treating heart failure
30 August 2026
thumbnail
Congress Presentation
Association between left ventricular strain and fibrosis in severe aortic regurgitation with preserved ejection fraction: a magnetic resonance and histology study
10 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources